ACTRN12618000245291已完成未知
The Biobrane®, RECELL® Autologous Cell Suspension and Silver Dressings Trial (BRACS Trial): A three arm prospective randomised controlled trial comparing a biological dressing (Biobrane®) with Biobrane® and RECELL® and with standard silver dressings in children with a superficial partial to mid dermal thickness burn
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 22
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- o limit 至 16 Years（—）
- 性别
- All
入选标准
- •1. Age 16 years or older
- •2. Burn depth of superficial partial to mid-dermal thickness burns
- •3. Able to be recruited and treated within 48hours of burn injury
- •4. TBSA 5% or greater
排除标准
- •1. Burn depth of superficial, deep dermal or full thickness depth
- •2. Patients whose injuries are deemed not compatible with life by the attending burns surgeon
研究者
相似试验
已完成
不适用
Autologous cell suspension grafting using ReCell in vitiligo and piebaldism patients: a randomized controlled pilot studyNL-OMON37399Stichting Nederlands Instituut voor Pigmentstoornissen10
已完成
不适用
Autologous cell suspension grafting using ReCell in vitiligo and piebaldism patients: a randomized controlled study on the recipient site preparatiosegmental vitiligo10035023piebaldismNL-OMON42082Academisch Medisch Centrum10
已完成
不适用
Autologous cell suspension grafting using ReNovaCell in non-segmental vitiligo patients: a randomized controlled studyNL-OMON46274Academisch Medisch Centrum20
已完成
不适用
Suspension from Patients own skin for correction of depressed area of faceCTRI/2016/11/007500AIIMS New Delhi10
进行中（未招募）
不适用
A NOVEL HYBRID PROTOCOL FOR RELAPSED GERM CELL TUMOURSWITH POOR PROGNOSIS - GAMIORelapsed Germ Cell Tumour with poor prognosisEUCTR2008-005295-27-GBBarts and The London NHS Trust47